Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information.
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information.
Abstract Introduction The COVID-19 pandemic focused attention on city parks as important public resources. However, monitoring park use over time poses practical challenges.
This article examines the consequences and causes of low enrollment of Black patients in clinical trials.
Politics and science have become increasingly intertwined.
This contribution surveys significant contributions technological innovations have made to humans' economic and material welfare, the seminal analysis made by noted economists, and the supportive poli
Background Prior research indicates that female physicians spend more time working in the electronic health record (EHR) than do male physicians. Objective To examine gender differences in EHR usage
We live in the digital century.
One of our great urbanists and one of our great public health experts join forces to reckon with how cities are changing in the face of existential threats the pandemic has only accelerated.
Past studies have found that racial and ethnic minorities are more likely than White drivers to be pulled over by the police for alleged traffic infractions, including a combination of speeding and eq
Containing the COVID-19 pandemic will confer global benefits that greatly exceed the costs but effective solutions require the redistribution of vaccines, technology, and other scarce resources from h
Get smart & reliable public policy insights right in your inbox.